Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
12,118,691
-
Share change
-
+166,399
-
Total reported value
-
$5,227,503
-
Price per share
-
$0.45
-
Number of holders
-
28
-
Value change
-
+$75,014
-
Number of buys
-
11
-
Number of sells
-
7
Institutional Holders of ACURA PHARMACEUTICALS INC - COM NEW (ACUR) as of Q4 2014
As of 31 Dec 2014,
ACURA PHARMACEUTICALS INC - COM NEW (ACUR) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,118,691 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, ROTHSCHILD INVESTMENT CORP /IL, RENAISSANCE TECHNOLOGIES LLC, Financial Advisory Service, Inc., NORTHERN TRUST CORP, Creative Planning, BlackRock Fund Advisors, and Citadel Advisors LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.